Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Consumer News Fda Warns Another Website Selling Unapproved Ozempic, Semaglutide Weight Loss Drugs is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
FDA tells another website to stop selling injectable semaglutide weight loss drugs - ConsumerAffairs

The feds are cracking down on unapproved sales of weight loss drugs claiming to contain Ozempic's active ingredient, semaglutide. Ozempen.com is the latest to get caught in the crosshairs. Ozempen ... Read More
FDA issues warning to companies about unapproved weight loss drugs - The Hill

The FDA has sent warning letters to companies selling unapproved weight loss drugs like semaglutide and tirzepatide, including Xcel Peptides, SwissChems, Summit Research and Prime Peptides. Read More
FDA Warns Against Unapproved, Compounded GLP-1 Weight Loss Drugs - MSN

The U.S. Food and Drug Administration (FDA) has issued a warning to patients and healthcare professionals regarding the use of unapproved versions of popular GLP-1 receptor agonist drugs like ... Read More
FDA warns consumers about risks of unapproved versions of weight loss drugs - MSN

The Federal Drug Administration (FDA) is warning consumers about unapproved semaglutide, a popular weight loss drug associated with the brand names Ozempic and Wegovy. Read More
Tennessee Attorney General warns of dangerous counterfeit GLP-1 weight loss drugs
GLP-1 drugs bought online or at compound pharmacies could cause harm, according to Tennessee Attorney General Jonathan Skrmetti. Read More
US FDA warns online vendors selling unapproved weight-loss drugs

The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved versions of GLP-1 drugs including semaglutide and tirzepatide, the active ... Read More
Could China’s New GLP-1 Drugs Beat Out Ozempic?
GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver disease and type 2 diabetes ... Read More
Warning: Fake weight loss drugs | Counterfeit Ozempic leads FDA message to consumers - ABC7 New York

NORTH CAROLINA -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have been found in the US drug supply chain. The FDA and the manufacturer ... Read More
Weight-Loss Drugs Sent Thousands to Emergency Room, Study Claims - People.com

Weight-Loss Drugs Have Sent a Shocking Number of People to the Emergency Room, New Study Claims Researchers believe nearly 25,000 hospital visits occurred, mostly due to gastrointestinal complications ... Read More
Warning: Fake weight loss drugs | Counterfeit Ozempic leads FDA message to consumers - ABC7 Chicago

NORTH CAROLINA -- A warning to consumers about fake Ozempic (semaglutide). The FDA issued this alert saying counterfeits have been found in the US drug supply chain.. The FDA and the manufacturer ... Read More
Blow Us A Whistle

Comments (Whistles) Designed By Disqus